Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Small Pharma Inc
(OP:
DMTTF
)
0.1117
UNCHANGED
Last Price
Updated: 3:59 PM EDT, Oct 20, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Small Pharma Inc
< Previous
1
2
3
4
5
6
7
Next >
Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event
March 13, 2023
The Benzinga Psychedelics Capital Conference (PCC) is rapidly becoming the place to be for all those interested or involved in the space. In addition to being the place where deals are done, you'll...
Via
Benzinga
Small Pharma Inc: Positive Clinical Data For Major Depressive Disorder, Upcoming Virtual Roundtable
March 08, 2023
Short-acting psychedelics biotech company Small Pharma Inc. (OTCQB: DMTTF) shared positive outcomes from its Phase 2a study of SPL026, the first placebo-controlled trial of the DMT-based short-duration...
Via
Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
February 21, 2023
Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and...
Via
Benzinga
Short-Acting Psychedelics: DMT-Based Drug Therapy Gets Tested In New Clinical Trial
February 15, 2023
Psychedelics biotech company Small Pharma Inc. (OTCQB: DMTTF) has dosed the first subject in its first-in-human clinical trial assessing proprietary DMT drug SPL028 paired with supportive therapy.
Via
Benzinga
Race Is On For Psychedelic DMT-Related Compounds, Small Pharma, Inc To Issue Two New Patents
February 01, 2023
After the positive results provided by its clinical trial assessing novel DMT’s effects on patients with Major Depressive Disorder (MDD), psychedelics biotech Small Pharma Inc.
Via
Benzinga
Small Pharma, Inc's Psychedelics For Major Depression Trial Results And Q1 Earnings
January 25, 2023
Short-acting psychedelics biotech Small Pharma Inc. (OTCQB: DMTTF)’s proprietary intravenous (IV) DMT-based drug SPL026 delivered positive topline results in a Phase 2a trial for the treatment of Major...
Via
Benzinga
Comparing Psychedelics' Administration Routes: Are Intramuscular Injections More Effective Than Intravenous?
January 11, 2023
Short-acting psychedelics biotech Small Pharma Inc. (OTCQB: DMTTF) has dosed the first patient in its Phase 1 clinical trial assessing intramuscular (IM) versus intravenous (IV) administration of its...
Via
Benzinga
Psyched: Canada's Psychedelic Therapy Guidelines, $39M Series B For Next-Gen Drugs, Mexico's Ancestral Roots & More
December 28, 2022
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries
Via
Benzinga
This IV Psychedelic-Based Compound Completes Phase 2a Trial, Company Gets Extra IP Coverage
December 22, 2022
Short-acting psychedelics biotech company Small Pharma Inc.
Via
Benzinga
Analyzing Psychedelics & Traditional Pharma Interaction: New Clinical Trial Begins Dosing
December 19, 2022
Psychedelics biotech Small Pharma Inc. (OTCQB: DMTTF) confirmed that the first patient has been dosed in its Phase 1b study assessing the interaction between selective serotonin reuptake inhibitors...
Via
Benzinga
How Certain Psychedelics Produce Brain And Behavior Changes: UCL Leads New Study
December 16, 2022
The University College London (UCL) is conducting a new research project called “Understanding Neuroplasticity Induced by Tryptamines (UNITy)” aimed at assessing brain changes and neuroplasticity...
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 24, 2022
November 24, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 23, 2022
November 23, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 8, 2022
November 08, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 3.85% at $0.14
Via
Benzinga
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
November 07, 2022
GAINERS: Allied (OTC:ALID) shares closed up 4.10% at $0.44
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 3, 2022
November 03, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.80% at $10.27
Via
Benzinga
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
November 02, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.90% at $10.39 LOSERS:
Via
Benzinga
This Novel Short-Acting Psychedelic Compound Is Ready For First Phase 1 Clinical Try-Out
October 31, 2022
Small Pharma Inc.
Via
Benzinga
Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today
October 27, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 3.00% at $0.87
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 26, 2022
October 26, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.39% at $0.18
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 25, 2022
October 25, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.24% at $10.39
Via
Benzinga
Allied, Small Pharma Among Top Psychedelic Movers Of Today
October 21, 2022
GAINERS: Allied (OTC:ALID) shares closed up 10.21% at $0.53
Via
Benzinga
This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More
October 19, 2022
Short-acting psychedelics biotech firm Small Pharma Inc.
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 18, 2022
October 18, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 15.76% at $0.14
Via
Benzinga
Small Pharma's Q2 2023 Financial Results, 'Ultra Short-Acting Psychedelic Program' Underway
October 18, 2022
Small Pharma Inc. (OTCQB: DMTTF), a biotech company developing short-acting psychedelic-assisted therapies for diverse mental health disorders, reported its financial results for the three and six...
Via
Benzinga
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
October 14, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.12% at $0.12
Via
Benzinga
Numinus Wellness, Small Pharma Among Top Psychedelic Movers Of Today
October 11, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 7.61% at $0.12
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 6, 2022
October 06, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 45.41% at $0.22
Via
Benzinga
Allied, GH Research Among Top Psychedelic Movers Of Today
October 04, 2022
GAINERS: Allied (OTC:ALID) shares closed up 31.58% at $0.60
Via
Benzinga
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today
September 26, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.91% at $0.13
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.